Key Takeaways
- Women experience significant, often unrecognized, physiological and hormonal shifts in midlife impacting overall well-being.
- Modern menopausal hormone support (MHS) uses safer hormones and delivery methods compared to older therapies, offering broad health benefits.
- Proactive health management, comprehensive medical workups, and lifestyle interventions are crucial for midlife women's health.
- Declining estrogen impacts brain health, increasing risks for cognitive issues like Alzheimer's and dementia.
- GLP-1s and minimizing exposure to endocrine disruptors like phthalates are emerging considerations for women's metabolic health.
Deep Dive
- Ovarian function declines between ages 35 and 40, leading to subtle metabolic changes like insulin resistance and visceral fat accumulation.
- Fluctuating estrogen levels contribute to brain health issues, including brain fog, memory lapses, and word-finding difficulties.
- Physiological changes during late reproductive years and early perimenopause include potential brain vascular changes, bone health decline, sarcopenia, and sleep disruption.
- Mood changes such as irritability, mood lability, and decreased 'joy de vie' are also noted.
- These changes are often dismissed as normal aging rather than treatable conditions, despite affecting overall well-being.
- The term 'hormone therapy' is evolving to 'menopausal hormone support' (MHS), distinguishing it from older oral preparations like Premarin and Provera.
- Modern MHS uses safer hormone types like estradiol (potentially safer than estrone) and natural progesterone, avoiding synthetic progestins linked to increased breast cancer risk.
- Transdermal delivery methods (patches, creams, gels) are presented as safer than oral estrogen, which can increase inflammation markers and blood clot risk.
- Modern MHS offers benefits including cardioprotection, brain health support, metabolic improvements (reduced insulin resistance), bone health protection, and symptomatic relief.
- Natural progesterone, approved around the time of the Women's Health Initiative (WHI) study, is not associated with elevated breast cancer risk.
- Contraindications for hormone therapy include a history of estrogen-dependent malignancies, where estrogen use is typically advised against.
- Previous strokes and heart attacks are considered relative contraindications, requiring specialist consultation; transdermal forms may pose less risk.
- Elevated calcium scores require careful consideration with a cardiologist before initiating hormone therapy.
- Abnormal vaginal bleeding is a contraindication that necessitates prior evaluation to rule out other issues.
- Selective estrogen receptor modulators (SERMs) like bazedoxifene (found in DUAVIVE) are emerging to manage symptoms while potentially reducing breast cancer risk.
- Women face an increased risk of Alzheimer's and dementia, with connections to hormonal changes during perimenopause and menopause.
- Physiological changes in perimenopause include cognitive issues like memory lapses and word-finding difficulties, correlating with brain energy metabolism and mitochondrial function changes.
- Fluctuating estrogen levels during menopause can lead to changes in brain volume, structure, and blood flow.
- Research suggests that estrogen replacement therapy, particularly transdermal forms, may help mitigate these brain changes and reduce the risk of dementia.
- Emerging data indicates estrogen therapy can improve brain biomarkers, with specific effects of transdermal estrogen on brain changes expected to be published soon.
- Women often face confusion and conflicting information regarding hormone therapy; consultation with women's health specialists is urged.
- Specialized algorithms are needed to guide practitioners in discussing hormone therapy with patients, particularly for women aged 35 to 60.
- Alternative medical interventions for managing menopausal symptoms include a new class of CNS-acting drugs like Vioza for hot flashes.
- Low-dose vaginal estrogens can effectively address issues like painful intercourse and dryness, even for women with contraindications to systemic estrogen.
- Low-dose birth control pills may also offer relief for some women experiencing perimenopausal symptoms.
- Key lab markers during hormonal transitions include day three FSH levels, comprehensive cholesterol panels (APOB, LP-little A), blood pressure, and insulin resistance indicators (HOMA IR, fasting insulin, Hemoglobin A1C).
- Waist-to-hip circumference is highlighted as a more meaningful metric for assessing body composition and visceral fat than BMI.
- Bone density testing (DEXA) is crucial, with advocacy for earlier intervention than the current recommendation to start at age 65.
- Detailed hormone mapping can involve checking serum hormone levels throughout a cycle or using home testing kits like Dutch testing for estrogen and progesterone metabolites.
- Triangulating data from home hormone tests, wearables, and physician insights is emphasized for comprehensive health assessment.
- Midlife is presented as a crucial, positive period for women to proactively take agency over their aging process and health.
- The essential pillars for health in midlife are identified as sleep, nutrition, and movement, with movement prioritized.
- A nutrition strategy emphasizing whole, plant-forward foods with adequate protein intake (around 30 grams per meal) is recommended.
- Many women (80-90%) are prompted to make health decisions due to physiological changes experienced in midlife.
- Beyond physical pillars, stress management, connectivity, mindset, purpose, happiness, and community are crucial for well-being.
- Nutrition strategies, particularly regarding carbohydrate tolerance, vary individually due to genetics.
- Strength training is emphasized over aerobic activity for women, with a recommendation to lift progressively heavier weights 3-4 days a week.
- Poor sleep significantly impacts metabolism by increasing cortisol and insulin resistance.
- Addressing insulin resistance can also improve sleep quality.
- Physicians often provide general advice, but women may require more targeted approaches for metabolism and muscle building.
- GLP-1s are presented as a valuable pharmacological intervention for women struggling with midlife weight gain and 'food noise,' especially when lifestyle changes are insufficient.
- GLP-1s can help reverse some metabolic disruptions caused by estrogen depletion, potentially working synergistically with estrogen intervention.
- Minimizing exposure to environmental endocrine disruptors like phthalates, BPAs, and parabens is crucial for hormone regulation.
- Practical steps to reduce exposure include using filtered water, choosing phthalate-free cosmetics, and avoiding plastic containers.
- Supplementation for brain health includes omega-3 fatty acids and creatine, with CoQ10 recommended for those on statins.
- GLP-1s show promise due to their anti-inflammatory properties, effective in reducing pain for endometriosis patients and potentially offering protection for the brain and heart against aging-related inflammation.
- When considering GLP-1s for longevity, monitoring body composition is vital to prevent muscle loss, requiring adequate protein intake and resistance training.
- Advice for men partnered with women experiencing hormonal shifts emphasizes recognizing these as real physiological changes impacting mood, libido, and causing pain.
- Partners are advised to show empathy and ensure women receive appropriate care, understanding that hormones directly impact neurotransmitters.
- The guest's podcast, 'Decoding Women's Health,' aims to provide women with accurate, expert-driven health information often lacking elsewhere.